nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenoxicam—PTGS2—glaucoma	0.558	1	CbGaD
Tenoxicam—CYP2C9—Diclofenamide—glaucoma	0.0539	0.354	CbGbCtD
Tenoxicam—CYP2C9—Dorzolamide—glaucoma	0.052	0.342	CbGbCtD
Tenoxicam—CYP2C9—Methazolamide—glaucoma	0.0464	0.304	CbGbCtD
Tenoxicam—Lornoxicam—PTGS2—glaucoma	0.0021	0.457	CrCbGaD
Tenoxicam—Meloxicam—PTGS2—glaucoma	0.00133	0.291	CrCbGaD
Tenoxicam—Piroxicam—PTGS2—glaucoma	0.00116	0.252	CrCbGaD
Tenoxicam—PTGS1—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00103	0.075	CbGpPWpGaD
Tenoxicam—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.000822	0.0596	CbGpPWpGaD
Tenoxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.000706	0.0512	CbGpPWpGaD
Tenoxicam—Hepatitis—Clonidine—glaucoma	0.000565	0.00209	CcSEcCtD
Tenoxicam—Dyspnoea—Bimatoprost—glaucoma	0.000561	0.00207	CcSEcCtD
Tenoxicam—PTGS2—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.000561	0.0406	CbGpPWpGaD
Tenoxicam—Rash—Carbachol—glaucoma	0.00056	0.00207	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00056	0.00207	CcSEcCtD
Tenoxicam—Dermatitis—Carbachol—glaucoma	0.00056	0.00207	CcSEcCtD
Tenoxicam—Fatigue—Apraclonidine—glaucoma	0.000559	0.00207	CcSEcCtD
Tenoxicam—Oedema—Brimonidine—glaucoma	0.000557	0.00206	CcSEcCtD
Tenoxicam—Headache—Carbachol—glaucoma	0.000557	0.00206	CcSEcCtD
Tenoxicam—Constipation—Apraclonidine—glaucoma	0.000555	0.00205	CcSEcCtD
Tenoxicam—Dyspepsia—Bimatoprost—glaucoma	0.000554	0.00204	CcSEcCtD
Tenoxicam—Leukopenia—Pilocarpine—glaucoma	0.000551	0.00204	CcSEcCtD
Tenoxicam—Nausea—Carteolol—glaucoma	0.00055	0.00203	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000549	0.00203	CcSEcCtD
Tenoxicam—Headache—Levobunolol—glaucoma	0.000548	0.00202	CcSEcCtD
Tenoxicam—Nervous system disorder—Brimonidine—glaucoma	0.000546	0.00202	CcSEcCtD
Tenoxicam—Palpitations—Pilocarpine—glaucoma	0.000544	0.00201	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000543	0.002	CcSEcCtD
Tenoxicam—Dry mouth—Dorzolamide—glaucoma	0.000543	0.002	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000542	0.002	CcSEcCtD
Tenoxicam—Skin disorder—Brimonidine—glaucoma	0.000541	0.002	CcSEcCtD
Tenoxicam—Nausea—Diclofenamide—glaucoma	0.000541	0.002	CcSEcCtD
Tenoxicam—Dry mouth—Travoprost—glaucoma	0.00054	0.00199	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Betaxolol—glaucoma	0.00054	0.00199	CcSEcCtD
Tenoxicam—Myocardial infarction—Betaxolol—glaucoma	0.000537	0.00198	CcSEcCtD
Tenoxicam—Dizziness—Latanoprost—glaucoma	0.000537	0.00198	CcSEcCtD
Tenoxicam—Stomatitis—Betaxolol—glaucoma	0.000534	0.00197	CcSEcCtD
Tenoxicam—Dry mouth—Brinzolamide—glaucoma	0.000534	0.00197	CcSEcCtD
Tenoxicam—Vomiting—Methazolamide—glaucoma	0.000533	0.00197	CcSEcCtD
Tenoxicam—Anaphylactic shock—Dorzolamide—glaucoma	0.000532	0.00196	CcSEcCtD
Tenoxicam—Oedema—Dorzolamide—glaucoma	0.000532	0.00196	CcSEcCtD
Tenoxicam—Oedema—Travoprost—glaucoma	0.00053	0.00196	CcSEcCtD
Tenoxicam—Rash—Methazolamide—glaucoma	0.000529	0.00195	CcSEcCtD
Tenoxicam—Dermatitis—Methazolamide—glaucoma	0.000528	0.00195	CcSEcCtD
Tenoxicam—Eye disorder—Clonidine—glaucoma	0.000528	0.00195	CcSEcCtD
Tenoxicam—Nausea—Carbachol—glaucoma	0.000528	0.00195	CcSEcCtD
Tenoxicam—Headache—Methazolamide—glaucoma	0.000525	0.00194	CcSEcCtD
Tenoxicam—Breast disorder—Timolol—glaucoma	0.000525	0.00194	CcSEcCtD
Tenoxicam—Cardiac disorder—Clonidine—glaucoma	0.000524	0.00194	CcSEcCtD
Tenoxicam—Nausea—Levobunolol—glaucoma	0.00052	0.00192	CcSEcCtD
Tenoxicam—Nervous system disorder—Travoprost—glaucoma	0.000519	0.00192	CcSEcCtD
Tenoxicam—Skin disorder—Travoprost—glaucoma	0.000515	0.0019	CcSEcCtD
Tenoxicam—Nervous system disorder—Brinzolamide—glaucoma	0.000513	0.00189	CcSEcCtD
Tenoxicam—Angiopathy—Clonidine—glaucoma	0.000513	0.00189	CcSEcCtD
Tenoxicam—Rash—Latanoprost—glaucoma	0.000512	0.00189	CcSEcCtD
Tenoxicam—Agranulocytosis—Betaxolol—glaucoma	0.000511	0.00189	CcSEcCtD
Tenoxicam—Dermatitis—Latanoprost—glaucoma	0.000511	0.00189	CcSEcCtD
Tenoxicam—Dyspepsia—Acetazolamide—glaucoma	0.000511	0.00189	CcSEcCtD
Tenoxicam—Headache—Latanoprost—glaucoma	0.000508	0.00188	CcSEcCtD
Tenoxicam—Skin disorder—Brinzolamide—glaucoma	0.000508	0.00188	CcSEcCtD
Tenoxicam—Anorexia—Dorzolamide—glaucoma	0.000507	0.00187	CcSEcCtD
Tenoxicam—Decreased appetite—Acetazolamide—glaucoma	0.000505	0.00186	CcSEcCtD
Tenoxicam—Oedema—Pilocarpine—glaucoma	0.000503	0.00186	CcSEcCtD
Tenoxicam—Asthma—Timolol—glaucoma	0.000502	0.00185	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000501	0.00185	CcSEcCtD
Tenoxicam—Fatigue—Acetazolamide—glaucoma	0.0005	0.00185	CcSEcCtD
Tenoxicam—Nausea—Methazolamide—glaucoma	0.000498	0.00184	CcSEcCtD
Tenoxicam—Dyspnoea—Brimonidine—glaucoma	0.000497	0.00183	CcSEcCtD
Tenoxicam—Mental disorder—Clonidine—glaucoma	0.000495	0.00183	CcSEcCtD
Tenoxicam—Thrombocytopenia—Pilocarpine—glaucoma	0.000492	0.00182	CcSEcCtD
Tenoxicam—Erythema—Clonidine—glaucoma	0.000492	0.00182	CcSEcCtD
Tenoxicam—Dyspepsia—Brimonidine—glaucoma	0.00049	0.00181	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Brimonidine—glaucoma	0.000481	0.00178	CcSEcCtD
Tenoxicam—Fatigue—Brimonidine—glaucoma	0.00048	0.00177	CcSEcCtD
Tenoxicam—Anorexia—Pilocarpine—glaucoma	0.000479	0.00177	CcSEcCtD
Tenoxicam—Hypersensitivity—Apraclonidine—glaucoma	0.000478	0.00176	CcSEcCtD
Tenoxicam—Dyspnoea—Dorzolamide—glaucoma	0.000474	0.00175	CcSEcCtD
Tenoxicam—Visual impairment—Betaxolol—glaucoma	0.000474	0.00175	CcSEcCtD
Tenoxicam—Dyspnoea—Travoprost—glaucoma	0.000472	0.00174	CcSEcCtD
Tenoxicam—Dyspepsia—Dorzolamide—glaucoma	0.000468	0.00173	CcSEcCtD
Tenoxicam—Dyspnoea—Brinzolamide—glaucoma	0.000466	0.00172	CcSEcCtD
Tenoxicam—Dyspepsia—Travoprost—glaucoma	0.000466	0.00172	CcSEcCtD
Tenoxicam—Asthenia—Apraclonidine—glaucoma	0.000466	0.00172	CcSEcCtD
Tenoxicam—Decreased appetite—Dorzolamide—glaucoma	0.000462	0.00171	CcSEcCtD
Tenoxicam—Urticaria—Acetazolamide—glaucoma	0.000461	0.0017	CcSEcCtD
Tenoxicam—Dyspepsia—Brinzolamide—glaucoma	0.00046	0.0017	CcSEcCtD
Tenoxicam—Eye disorder—Betaxolol—glaucoma	0.00046	0.0017	CcSEcCtD
Tenoxicam—Pruritus—Apraclonidine—glaucoma	0.000459	0.00169	CcSEcCtD
Tenoxicam—Fatigue—Dorzolamide—glaucoma	0.000459	0.00169	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Travoprost—glaucoma	0.000457	0.00169	CcSEcCtD
Tenoxicam—Fatigue—Travoprost—glaucoma	0.000457	0.00169	CcSEcCtD
Tenoxicam—Cardiac disorder—Betaxolol—glaucoma	0.000457	0.00169	CcSEcCtD
Tenoxicam—Decreased appetite—Brinzolamide—glaucoma	0.000455	0.00168	CcSEcCtD
Tenoxicam—Constipation—Travoprost—glaucoma	0.000453	0.00167	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000452	0.00167	CcSEcCtD
Tenoxicam—Asthenia—Bimatoprost—glaucoma	0.000451	0.00167	CcSEcCtD
Tenoxicam—Fatigue—Brinzolamide—glaucoma	0.000451	0.00166	CcSEcCtD
Tenoxicam—Angioedema—Clonidine—glaucoma	0.000449	0.00166	CcSEcCtD
Tenoxicam—Dyspnoea—Pilocarpine—glaucoma	0.000448	0.00165	CcSEcCtD
Tenoxicam—Angiopathy—Betaxolol—glaucoma	0.000446	0.00165	CcSEcCtD
Tenoxicam—Pruritus—Bimatoprost—glaucoma	0.000445	0.00164	CcSEcCtD
Tenoxicam—Immune system disorder—Betaxolol—glaucoma	0.000444	0.00164	CcSEcCtD
Tenoxicam—Diarrhoea—Apraclonidine—glaucoma	0.000444	0.00164	CcSEcCtD
Tenoxicam—Dyspepsia—Pilocarpine—glaucoma	0.000442	0.00163	CcSEcCtD
Tenoxicam—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000439	0.0319	CbGpPWpGaD
Tenoxicam—Decreased appetite—Pilocarpine—glaucoma	0.000437	0.00161	CcSEcCtD
Tenoxicam—Palpitations—Clonidine—glaucoma	0.000435	0.0016	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000434	0.0016	CcSEcCtD
Tenoxicam—Mental disorder—Betaxolol—glaucoma	0.000431	0.00159	CcSEcCtD
Tenoxicam—Constipation—Pilocarpine—glaucoma	0.00043	0.00159	CcSEcCtD
Tenoxicam—Dizziness—Apraclonidine—glaucoma	0.000429	0.00158	CcSEcCtD
Tenoxicam—Erythema—Betaxolol—glaucoma	0.000428	0.00158	CcSEcCtD
Tenoxicam—Malnutrition—Betaxolol—glaucoma	0.000428	0.00158	CcSEcCtD
Tenoxicam—Urticaria—Dorzolamide—glaucoma	0.000423	0.00156	CcSEcCtD
Tenoxicam—Agranulocytosis—Timolol—glaucoma	0.000418	0.00154	CcSEcCtD
Tenoxicam—Asthenia—Acetazolamide—glaucoma	0.000416	0.00154	CcSEcCtD
Tenoxicam—Dizziness—Bimatoprost—glaucoma	0.000416	0.00154	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000416	0.00154	CcSEcCtD
Tenoxicam—Urticaria—Brinzolamide—glaucoma	0.000415	0.00153	CcSEcCtD
Tenoxicam—Vomiting—Apraclonidine—glaucoma	0.000413	0.00152	CcSEcCtD
Tenoxicam—Hypersensitivity—Brimonidine—glaucoma	0.00041	0.00152	CcSEcCtD
Tenoxicam—Dry mouth—Clonidine—glaucoma	0.00041	0.00151	CcSEcCtD
Tenoxicam—Dermatitis—Apraclonidine—glaucoma	0.000409	0.00151	CcSEcCtD
Tenoxicam—Headache—Apraclonidine—glaucoma	0.000406	0.0015	CcSEcCtD
Tenoxicam—Oedema—Clonidine—glaucoma	0.000401	0.00148	CcSEcCtD
Tenoxicam—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.0004	0.029	CbGpPWpGaD
Tenoxicam—Asthenia—Brimonidine—glaucoma	0.0004	0.00148	CcSEcCtD
Tenoxicam—Diarrhoea—Acetazolamide—glaucoma	0.000397	0.00147	CcSEcCtD
Tenoxicam—Rash—Bimatoprost—glaucoma	0.000397	0.00146	CcSEcCtD
Tenoxicam—Dermatitis—Bimatoprost—glaucoma	0.000396	0.00146	CcSEcCtD
Tenoxicam—Anaemia—Betaxolol—glaucoma	0.000396	0.00146	CcSEcCtD
Tenoxicam—Pruritus—Brimonidine—glaucoma	0.000394	0.00145	CcSEcCtD
Tenoxicam—Headache—Bimatoprost—glaucoma	0.000394	0.00145	CcSEcCtD
Tenoxicam—Nervous system disorder—Clonidine—glaucoma	0.000394	0.00145	CcSEcCtD
Tenoxicam—Thrombocytopenia—Clonidine—glaucoma	0.000393	0.00145	CcSEcCtD
Tenoxicam—Hypersensitivity—Dorzolamide—glaucoma	0.000392	0.00145	CcSEcCtD
Tenoxicam—Hypersensitivity—Travoprost—glaucoma	0.00039	0.00144	CcSEcCtD
Tenoxicam—Skin disorder—Clonidine—glaucoma	0.00039	0.00144	CcSEcCtD
Tenoxicam—Visual impairment—Timolol—glaucoma	0.000387	0.00143	CcSEcCtD
Tenoxicam—Nausea—Apraclonidine—glaucoma	0.000385	0.00142	CcSEcCtD
Tenoxicam—Hypersensitivity—Brinzolamide—glaucoma	0.000385	0.00142	CcSEcCtD
Tenoxicam—Vertigo—Betaxolol—glaucoma	0.000385	0.00142	CcSEcCtD
Tenoxicam—Dizziness—Acetazolamide—glaucoma	0.000384	0.00142	CcSEcCtD
Tenoxicam—Anorexia—Clonidine—glaucoma	0.000383	0.00141	CcSEcCtD
Tenoxicam—Asthenia—Dorzolamide—glaucoma	0.000382	0.00141	CcSEcCtD
Tenoxicam—Asthenia—Travoprost—glaucoma	0.00038	0.0014	CcSEcCtD
Tenoxicam—Palpitations—Betaxolol—glaucoma	0.000378	0.0014	CcSEcCtD
Tenoxicam—Pruritus—Dorzolamide—glaucoma	0.000376	0.00139	CcSEcCtD
Tenoxicam—Eye disorder—Timolol—glaucoma	0.000376	0.00139	CcSEcCtD
Tenoxicam—Asthenia—Brinzolamide—glaucoma	0.000375	0.00139	CcSEcCtD
Tenoxicam—Pruritus—Travoprost—glaucoma	0.000375	0.00138	CcSEcCtD
Tenoxicam—Nausea—Bimatoprost—glaucoma	0.000374	0.00138	CcSEcCtD
Tenoxicam—Cardiac disorder—Timolol—glaucoma	0.000373	0.00138	CcSEcCtD
Tenoxicam—Hypersensitivity—Pilocarpine—glaucoma	0.00037	0.00137	CcSEcCtD
Tenoxicam—Pruritus—Brinzolamide—glaucoma	0.00037	0.00137	CcSEcCtD
Tenoxicam—Vomiting—Acetazolamide—glaucoma	0.000369	0.00136	CcSEcCtD
Tenoxicam—Dizziness—Brimonidine—glaucoma	0.000368	0.00136	CcSEcCtD
Tenoxicam—Angiopathy—Timolol—glaucoma	0.000365	0.00135	CcSEcCtD
Tenoxicam—Diarrhoea—Dorzolamide—glaucoma	0.000364	0.00134	CcSEcCtD
Tenoxicam—Headache—Acetazolamide—glaucoma	0.000364	0.00134	CcSEcCtD
Tenoxicam—Immune system disorder—Timolol—glaucoma	0.000363	0.00134	CcSEcCtD
Tenoxicam—Diarrhoea—Travoprost—glaucoma	0.000362	0.00134	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000362	0.00134	CcSEcCtD
Tenoxicam—Asthenia—Pilocarpine—glaucoma	0.000361	0.00133	CcSEcCtD
Tenoxicam—Dyspnoea—Clonidine—glaucoma	0.000358	0.00132	CcSEcCtD
Tenoxicam—Diarrhoea—Brinzolamide—glaucoma	0.000358	0.00132	CcSEcCtD
Tenoxicam—Dry mouth—Betaxolol—glaucoma	0.000357	0.00132	CcSEcCtD
Tenoxicam—Pruritus—Pilocarpine—glaucoma	0.000356	0.00131	CcSEcCtD
Tenoxicam—Mental disorder—Timolol—glaucoma	0.000352	0.0013	CcSEcCtD
Tenoxicam—Dizziness—Dorzolamide—glaucoma	0.000352	0.0013	CcSEcCtD
Tenoxicam—Rash—Brimonidine—glaucoma	0.000351	0.0013	CcSEcCtD
Tenoxicam—Dermatitis—Brimonidine—glaucoma	0.000351	0.0013	CcSEcCtD
Tenoxicam—Dizziness—Travoprost—glaucoma	0.00035	0.00129	CcSEcCtD
Tenoxicam—Malnutrition—Timolol—glaucoma	0.00035	0.00129	CcSEcCtD
Tenoxicam—Erythema—Timolol—glaucoma	0.00035	0.00129	CcSEcCtD
Tenoxicam—Oedema—Betaxolol—glaucoma	0.000349	0.00129	CcSEcCtD
Tenoxicam—Headache—Brimonidine—glaucoma	0.000349	0.00129	CcSEcCtD
Tenoxicam—Decreased appetite—Clonidine—glaucoma	0.000349	0.00129	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Clonidine—glaucoma	0.000347	0.00128	CcSEcCtD
Tenoxicam—Fatigue—Clonidine—glaucoma	0.000346	0.00128	CcSEcCtD
Tenoxicam—Dizziness—Brinzolamide—glaucoma	0.000346	0.00128	CcSEcCtD
Tenoxicam—Nausea—Acetazolamide—glaucoma	0.000345	0.00127	CcSEcCtD
Tenoxicam—Diarrhoea—Pilocarpine—glaucoma	0.000344	0.00127	CcSEcCtD
Tenoxicam—Constipation—Clonidine—glaucoma	0.000343	0.00127	CcSEcCtD
Tenoxicam—Nervous system disorder—Betaxolol—glaucoma	0.000343	0.00127	CcSEcCtD
Tenoxicam—Thrombocytopenia—Betaxolol—glaucoma	0.000342	0.00126	CcSEcCtD
Tenoxicam—Skin disorder—Betaxolol—glaucoma	0.000339	0.00125	CcSEcCtD
Tenoxicam—Vomiting—Dorzolamide—glaucoma	0.000338	0.00125	CcSEcCtD
Tenoxicam—Rash—Dorzolamide—glaucoma	0.000335	0.00124	CcSEcCtD
Tenoxicam—Dermatitis—Dorzolamide—glaucoma	0.000335	0.00124	CcSEcCtD
Tenoxicam—Rash—Travoprost—glaucoma	0.000334	0.00123	CcSEcCtD
Tenoxicam—Dermatitis—Travoprost—glaucoma	0.000334	0.00123	CcSEcCtD
Tenoxicam—Headache—Dorzolamide—glaucoma	0.000333	0.00123	CcSEcCtD
Tenoxicam—Anorexia—Betaxolol—glaucoma	0.000333	0.00123	CcSEcCtD
Tenoxicam—Vomiting—Brinzolamide—glaucoma	0.000333	0.00123	CcSEcCtD
Tenoxicam—Dizziness—Pilocarpine—glaucoma	0.000332	0.00123	CcSEcCtD
Tenoxicam—Headache—Travoprost—glaucoma	0.000332	0.00122	CcSEcCtD
Tenoxicam—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000331	0.024	CbGpPWpGaD
Tenoxicam—Nausea—Brimonidine—glaucoma	0.000331	0.00122	CcSEcCtD
Tenoxicam—Rash—Brinzolamide—glaucoma	0.00033	0.00122	CcSEcCtD
Tenoxicam—Dermatitis—Brinzolamide—glaucoma	0.000329	0.00122	CcSEcCtD
Tenoxicam—Headache—Brinzolamide—glaucoma	0.000328	0.00121	CcSEcCtD
Tenoxicam—Angioedema—Timolol—glaucoma	0.00032	0.00118	CcSEcCtD
Tenoxicam—Vomiting—Pilocarpine—glaucoma	0.00032	0.00118	CcSEcCtD
Tenoxicam—Urticaria—Clonidine—glaucoma	0.000319	0.00118	CcSEcCtD
Tenoxicam—Rash—Pilocarpine—glaucoma	0.000317	0.00117	CcSEcCtD
Tenoxicam—Dermatitis—Pilocarpine—glaucoma	0.000317	0.00117	CcSEcCtD
Tenoxicam—Nausea—Dorzolamide—glaucoma	0.000316	0.00117	CcSEcCtD
Tenoxicam—Headache—Pilocarpine—glaucoma	0.000315	0.00116	CcSEcCtD
Tenoxicam—Nausea—Travoprost—glaucoma	0.000315	0.00116	CcSEcCtD
Tenoxicam—Vertigo—Timolol—glaucoma	0.000314	0.00116	CcSEcCtD
Tenoxicam—Dyspnoea—Betaxolol—glaucoma	0.000312	0.00115	CcSEcCtD
Tenoxicam—Nausea—Brinzolamide—glaucoma	0.000311	0.00115	CcSEcCtD
Tenoxicam—Palpitations—Timolol—glaucoma	0.000309	0.00114	CcSEcCtD
Tenoxicam—Dyspepsia—Betaxolol—glaucoma	0.000308	0.00114	CcSEcCtD
Tenoxicam—Decreased appetite—Betaxolol—glaucoma	0.000304	0.00112	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Betaxolol—glaucoma	0.000302	0.00111	CcSEcCtD
Tenoxicam—Fatigue—Betaxolol—glaucoma	0.000301	0.00111	CcSEcCtD
Tenoxicam—Constipation—Betaxolol—glaucoma	0.000299	0.0011	CcSEcCtD
Tenoxicam—Nausea—Pilocarpine—glaucoma	0.000299	0.0011	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000296	0.00109	CcSEcCtD
Tenoxicam—Hypersensitivity—Clonidine—glaucoma	0.000296	0.00109	CcSEcCtD
Tenoxicam—Dry mouth—Timolol—glaucoma	0.000291	0.00108	CcSEcCtD
Tenoxicam—Asthenia—Clonidine—glaucoma	0.000288	0.00106	CcSEcCtD
Tenoxicam—Anaphylactic shock—Timolol—glaucoma	0.000286	0.00105	CcSEcCtD
Tenoxicam—Oedema—Timolol—glaucoma	0.000286	0.00105	CcSEcCtD
Tenoxicam—Pruritus—Clonidine—glaucoma	0.000284	0.00105	CcSEcCtD
Tenoxicam—Nervous system disorder—Timolol—glaucoma	0.00028	0.00103	CcSEcCtD
Tenoxicam—Urticaria—Betaxolol—glaucoma	0.000278	0.00102	CcSEcCtD
Tenoxicam—Skin disorder—Timolol—glaucoma	0.000277	0.00102	CcSEcCtD
Tenoxicam—Diarrhoea—Clonidine—glaucoma	0.000275	0.00101	CcSEcCtD
Tenoxicam—Anorexia—Timolol—glaucoma	0.000272	0.001	CcSEcCtD
Tenoxicam—Dizziness—Clonidine—glaucoma	0.000265	0.00098	CcSEcCtD
Tenoxicam—PTGS1—Overview of nanoparticle effects—FN1—glaucoma	0.00026	0.0188	CbGpPWpGaD
Tenoxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	0.000259	0.0188	CbGpPWpGaD
Tenoxicam—Hypersensitivity—Betaxolol—glaucoma	0.000257	0.000951	CcSEcCtD
Tenoxicam—Vomiting—Clonidine—glaucoma	0.000255	0.000942	CcSEcCtD
Tenoxicam—Dyspnoea—Timolol—glaucoma	0.000255	0.00094	CcSEcCtD
Tenoxicam—PTGS2—C-MYB transcription factor network—CA1—glaucoma	0.000254	0.0184	CbGpPWpGaD
Tenoxicam—Rash—Clonidine—glaucoma	0.000253	0.000934	CcSEcCtD
Tenoxicam—Dermatitis—Clonidine—glaucoma	0.000253	0.000933	CcSEcCtD
Tenoxicam—Headache—Clonidine—glaucoma	0.000251	0.000928	CcSEcCtD
Tenoxicam—Dyspepsia—Timolol—glaucoma	0.000251	0.000928	CcSEcCtD
Tenoxicam—Asthenia—Betaxolol—glaucoma	0.000251	0.000926	CcSEcCtD
Tenoxicam—Decreased appetite—Timolol—glaucoma	0.000248	0.000916	CcSEcCtD
Tenoxicam—Pruritus—Betaxolol—glaucoma	0.000247	0.000913	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Timolol—glaucoma	0.000246	0.00091	CcSEcCtD
Tenoxicam—Fatigue—Timolol—glaucoma	0.000246	0.000909	CcSEcCtD
Tenoxicam—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000242	0.0176	CbGpPWpGaD
Tenoxicam—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—glaucoma	0.000241	0.0175	CbGpPWpGaD
Tenoxicam—Diarrhoea—Betaxolol—glaucoma	0.000239	0.000883	CcSEcCtD
Tenoxicam—Nausea—Clonidine—glaucoma	0.000238	0.00088	CcSEcCtD
Tenoxicam—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000235	0.017	CbGpPWpGaD
Tenoxicam—Dizziness—Betaxolol—glaucoma	0.000231	0.000853	CcSEcCtD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000229	0.0166	CbGpPWpGaD
Tenoxicam—Urticaria—Timolol—glaucoma	0.000227	0.000837	CcSEcCtD
Tenoxicam—SLC22A8—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000226	0.0164	CbGpPWpGaD
Tenoxicam—Vomiting—Betaxolol—glaucoma	0.000222	0.00082	CcSEcCtD
Tenoxicam—Rash—Betaxolol—glaucoma	0.00022	0.000813	CcSEcCtD
Tenoxicam—Dermatitis—Betaxolol—glaucoma	0.00022	0.000813	CcSEcCtD
Tenoxicam—Headache—Betaxolol—glaucoma	0.000219	0.000808	CcSEcCtD
Tenoxicam—Hypersensitivity—Timolol—glaucoma	0.00021	0.000777	CcSEcCtD
Tenoxicam—Nausea—Betaxolol—glaucoma	0.000208	0.000766	CcSEcCtD
Tenoxicam—PTGS2—Overview of nanoparticle effects—FN1—glaucoma	0.000206	0.0149	CbGpPWpGaD
Tenoxicam—Asthenia—Timolol—glaucoma	0.000205	0.000756	CcSEcCtD
Tenoxicam—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000203	0.0147	CbGpPWpGaD
Tenoxicam—Pruritus—Timolol—glaucoma	0.000202	0.000746	CcSEcCtD
Tenoxicam—PTGS1—Selenium Micronutrient Network—TXN—glaucoma	0.000199	0.0144	CbGpPWpGaD
Tenoxicam—Diarrhoea—Timolol—glaucoma	0.000195	0.000721	CcSEcCtD
Tenoxicam—PTGS1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000193	0.014	CbGpPWpGaD
Tenoxicam—Dizziness—Timolol—glaucoma	0.000189	0.000697	CcSEcCtD
Tenoxicam—PTGS1—Overview of nanoparticle effects—PTGS2—glaucoma	0.000189	0.0137	CbGpPWpGaD
Tenoxicam—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000186	0.0135	CbGpPWpGaD
Tenoxicam—Vomiting—Timolol—glaucoma	0.000182	0.00067	CcSEcCtD
Tenoxicam—Rash—Timolol—glaucoma	0.00018	0.000665	CcSEcCtD
Tenoxicam—Dermatitis—Timolol—glaucoma	0.00018	0.000664	CcSEcCtD
Tenoxicam—Headache—Timolol—glaucoma	0.000179	0.00066	CcSEcCtD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—PEX19—glaucoma	0.00017	0.0123	CbGpPWpGaD
Tenoxicam—Nausea—Timolol—glaucoma	0.00017	0.000626	CcSEcCtD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000164	0.0119	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—TXN—glaucoma	0.000158	0.0114	CbGpPWpGaD
Tenoxicam—PTGS1—Eicosanoid Synthesis—PTGS2—glaucoma	0.000156	0.0113	CbGpPWpGaD
Tenoxicam—PTGS2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000153	0.0111	CbGpPWpGaD
Tenoxicam—SLC22A8—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000151	0.0109	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—C1QB—glaucoma	0.00014	0.0101	CbGpPWpGaD
Tenoxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000138	0.01	CbGpPWpGaD
Tenoxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000135	0.00981	CbGpPWpGaD
Tenoxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000135	0.0098	CbGpPWpGaD
Tenoxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000131	0.00949	CbGpPWpGaD
Tenoxicam—PTGS1—Overview of nanoparticle effects—TNF—glaucoma	0.000127	0.00923	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—ABCA1—glaucoma	0.000123	0.0089	CbGpPWpGaD
Tenoxicam—PTGS2—S1P1 pathway—VEGFA—glaucoma	0.000118	0.00855	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000115	0.00831	CbGpPWpGaD
Tenoxicam—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.00011	0.00799	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—SOD1—glaucoma	0.000109	0.00793	CbGpPWpGaD
Tenoxicam—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000101	0.00735	CbGpPWpGaD
Tenoxicam—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	0.000101	0.00733	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	9.74e-05	0.00706	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—GSTT1—glaucoma	9.01e-05	0.00653	CbGpPWpGaD
Tenoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.77e-05	0.00636	CbGpPWpGaD
Tenoxicam—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	8.69e-05	0.0063	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	8.68e-05	0.0063	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	8.67e-05	0.00629	CbGpPWpGaD
Tenoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.65e-05	0.00627	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	8.08e-05	0.00586	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.65e-05	0.00555	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—NGFR—glaucoma	7.42e-05	0.00538	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—CYP1B1—glaucoma	7.18e-05	0.00521	CbGpPWpGaD
Tenoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.11e-05	0.00515	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	6.99e-05	0.00507	CbGpPWpGaD
Tenoxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	6.95e-05	0.00504	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	6.88e-05	0.00499	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.71e-05	0.00486	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—BDNF—glaucoma	6.45e-05	0.00468	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	6.43e-05	0.00466	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CA5A—glaucoma	6.32e-05	0.00458	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NARFL—glaucoma	6.32e-05	0.00458	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—IL1A—glaucoma	6.2e-05	0.00449	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	5.81e-05	0.00421	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—GSTM1—glaucoma	5.74e-05	0.00416	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.6e-05	0.00406	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	5.53e-05	0.00401	CbGpPWpGaD
Tenoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	5.46e-05	0.00396	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.32e-05	0.00386	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CA5A—glaucoma	5.01e-05	0.00364	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NARFL—glaucoma	5.01e-05	0.00364	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	4.98e-05	0.00361	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	4.87e-05	0.00353	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	4.79e-05	0.00348	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—GSTT1—glaucoma	4.74e-05	0.00343	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	4.66e-05	0.00338	CbGpPWpGaD
Tenoxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	4.57e-05	0.00331	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—LRP12—glaucoma	4.54e-05	0.00329	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	4.42e-05	0.0032	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	4.39e-05	0.00318	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	4.32e-05	0.00313	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—CYP1B1—glaucoma	3.77e-05	0.00274	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	3.76e-05	0.00272	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	3.73e-05	0.00271	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	3.72e-05	0.0027	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.53e-05	0.00256	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NARFL—glaucoma	3.32e-05	0.00241	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CA5A—glaucoma	3.32e-05	0.00241	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	3.29e-05	0.00238	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	3.21e-05	0.00233	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CA1—glaucoma	3.08e-05	0.00224	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MMP9—glaucoma	3.05e-05	0.00221	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—GSTM1—glaucoma	3.02e-05	0.00219	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CTSA—glaucoma	2.99e-05	0.00217	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.98e-05	0.00216	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	2.96e-05	0.00215	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FGFR1OP—glaucoma	2.92e-05	0.00212	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HEYL—glaucoma	2.92e-05	0.00212	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CA2—glaucoma	2.82e-05	0.00205	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.76e-05	0.002	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.76e-05	0.002	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CA1—glaucoma	2.45e-05	0.00178	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CTSA—glaucoma	2.37e-05	0.00172	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TNF—glaucoma	2.34e-05	0.0017	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CA2—glaucoma	2.24e-05	0.00162	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.24e-05	0.00162	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.19e-05	0.00159	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.19e-05	0.00159	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TP53—glaucoma	2.07e-05	0.0015	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—TXN—glaucoma	1.99e-05	0.00144	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.86e-05	0.00135	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HDAC9—glaucoma	1.82e-05	0.00132	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.81e-05	0.00131	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.8e-05	0.0013	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CA1—glaucoma	1.62e-05	0.00118	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.59e-05	0.00116	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—TXN—glaucoma	1.58e-05	0.00114	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CTSA—glaucoma	1.57e-05	0.00114	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTT1—glaucoma	1.54e-05	0.00112	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CA2—glaucoma	1.48e-05	0.00108	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.45e-05	0.00105	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.45e-05	0.00105	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.44e-05	0.00104	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.43e-05	0.00103	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.41e-05	0.00102	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.24e-05	0.000901	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ABCA1—glaucoma	1.23e-05	0.00089	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP1B1—glaucoma	1.23e-05	0.00089	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTT1—glaucoma	1.22e-05	0.000887	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—TXN—glaucoma	1.04e-05	0.000758	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTM1—glaucoma	9.82e-06	0.000712	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CDKN2B—glaucoma	9.81e-06	0.000711	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP1B1—glaucoma	9.75e-06	0.000707	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ABCA1—glaucoma	9.75e-06	0.000707	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.53e-06	0.000691	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.45e-06	0.000685	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—MTHFR—glaucoma	8.68e-06	0.000629	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MTHFR—glaucoma	8.22e-06	0.000596	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTT1—glaucoma	8.1e-06	0.000587	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—APOE—glaucoma	8.08e-06	0.000586	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CAV1—glaucoma	8e-06	0.00058	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTM1—glaucoma	7.79e-06	0.000565	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—APOE—glaucoma	7.66e-06	0.000555	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CAV1—glaucoma	7.59e-06	0.00055	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—BAD—glaucoma	7.13e-06	0.000517	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—MTHFR—glaucoma	6.89e-06	0.000499	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.53e-06	0.000474	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ABCA1—glaucoma	6.46e-06	0.000468	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP1B1—glaucoma	6.46e-06	0.000468	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—APOE—glaucoma	6.41e-06	0.000465	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CAV1—glaucoma	6.35e-06	0.000461	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NOS3—glaucoma	6.05e-06	0.000439	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NOS3—glaucoma	5.74e-06	0.000416	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PTGS2—glaucoma	5.53e-06	0.000401	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTM1—glaucoma	5.16e-06	0.000374	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CDKN1B—glaucoma	4.97e-06	0.00036	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NOS3—glaucoma	4.8e-06	0.000348	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—MTHFR—glaucoma	4.56e-06	0.000331	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—APOE—glaucoma	4.25e-06	0.000308	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CAV1—glaucoma	4.21e-06	0.000305	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NOS3—glaucoma	3.18e-06	0.000231	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PTGS2—glaucoma	2.91e-06	0.000211	CbGpPWpGaD
